Radium-223 dichloride (Xofigo)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Radium-223 dichloride (Xofigo), covering 2016-10-14 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer